Amazon.com: Pediatric Drug Development: Concepts and Applications (v. 1) (9780470169292): Andrew E. Mulberg, Steven A. Silber, John N. van den Anker: Books
Pediatric Drug Development: Concepts and Applications: v. 1 and over one million other books are available for Amazon Kindle. Learn more


or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
Kindle Edition
 
   
Sell Back Your Copy
For a $5.41 Gift Card
Trade in
More Buying Choices
Have one to sell? Sell yours here
Pediatric Drug Development: Concepts and Applications (v. 1)
 
 
Start reading Pediatric Drug Development: Concepts and Applications: v. 1 on your Kindle in under a minute.

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Pediatric Drug Development: Concepts and Applications (v. 1) [Hardcover]

Andrew E. Mulberg (Author), Steven A. Silber (Author), John N. van den Anker (Author)
5.0 out of 5 stars  See all reviews (1 customer review)

List Price: $139.95
Price: $121.62 & this item ships for FREE with Super Saver Shipping. Details
You Save: $18.33 (13%)
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 2 left in stock--order soon (more on the way).
Want it delivered Wednesday, February 29? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for students on millions of items. Learn more

Formats

Amazon Price New from Used from
Kindle Edition $76.97  
Hardcover $121.62  
Sell Back Your Copy for $5.41
Whether you buy it used on Amazon for $110.29 or somewhere else, you can sell it back through our Book Trade-In Program at the current price of $5.41.
Used Price$110.29
Trade-in Price$5.41
Price after
Trade-in
$104.88

Book Description

April 13, 2009 047016929X 978-0470169292 1
Pediatric Drug Development: Concepts and Applications is designed as a reference and textbook and is meant to address the science of differences between the pediatric and adult subject in the development of pharmaceutical products. Considered are the ethics and medical needs of proper understanding the pediatric and adult differences, the business case for proper development of drugs for children, as well as the technical feasibility studies and processes that are necessary for a proper pediatric drug development program. The applications of these approaches will benefit all stakeholders and ultimately not only educate but also provide better and safer drugs for pediatric patients.

Customers Who Bought This Item Also Bought


Editorial Reviews

From the Back Cover

The first comprehensive treatmentof this vital topic

For decades, the specific needs of infants, children, and adolescents have been largely ignored in the drug development process, and healthcare providers have most often had to make do with "pediatric dosing" of drugs that were developed and intended for adults. Now, an awareness of the differences between the pediatric patient and the adult patient have begun to be realized and addressed by the pharmaceutical and wider healthcare industries, as well as the governmental and regulatory bodies that sanction the development and testing of drugs for children.

This is the first book to provide a comprehensive treatment of pediatric drug development. Written by a team of experts, it provides industry, academia, and governmental agencies with an understanding of how to properly develop drugs for children without compromising business objectives. The authors address the scientific differences between the pediatric and adult subject in the development of pharmaceutical products. They discuss and consider: ethics—from product concept to production; specific medical needs of children; business rationale for the proper development of drugs for children; and the technical feasibility of studies and processes that are necessary for a proper pediatric drug development program.

The book clearly explains the challenges and opportunities facing the entire healthcare community as it strives to improve the health of children worldwide. It demonstrates how these approaches will benefit all stakeholders and, ultimately, provide better and safer drugs for the pediatric population at large.

This timely new work is essential reading for academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in pediatric drug development. It also serves as an important textbook for students in pharmacy, science, and medicine courses.

About the Author

Andrew E. Mulberg, MD, is Director of Pediatric Drug Development for Johnson and Johnson Pharmaceutical Research and Development, LLC, in Titusville, New Jersey, and is has been editor for four editions of the best-selling 5-Minute Pediatric Consult.

Steven A. Silber, MD, is Vice President for Drug Development and Safety with McNeil Pediatrics, Ortho-McNeil Women's Health and Urology, in Fort Washington, Pennsylvania.

John N. van den Anker, MD, PhD, is Executive Director of the Pediatric Pharmacology Research Unit and Director of Pediatric Clinical Pharmacology at the Children's National Medical Center, Washington, DC, and Professor of Pediatrics, Pharmacology and Physiology at George Washington University, Washington, DC, as well as an Adjunct Professor of Pediatrics at Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.


Product Details

  • Hardcover: 704 pages
  • Publisher: Wiley-Blackwell; 1 edition (April 13, 2009)
  • Language: English
  • ISBN-10: 047016929X
  • ISBN-13: 978-0470169292
  • Product Dimensions: 9.8 x 7.2 x 1.6 inches
  • Shipping Weight: 3 pounds (View shipping rates and policies)
  • Average Customer Review: 5.0 out of 5 stars  See all reviews (1 customer review)
  • Amazon Best Sellers Rank: #1,398,139 in Books (See Top 100 in Books)

 

Customer Reviews

1 Review
5 star:
 (1)
4 star:    (0)
3 star:    (0)
2 star:    (0)
1 star:    (0)
 
 
 
 
 
Average Customer Review
5.0 out of 5 stars (1 customer review)
 
 
 
 
Share your thoughts with other customers:
Most Helpful Customer Reviews

1 of 1 people found the following review helpful:
5.0 out of 5 stars Truly Honest with superb integrity, August 4, 2009
A Kid's Review
This review is from: Pediatric Drug Development: Concepts and Applications (v. 1) (Hardcover)
This book, more of a textbook, taught me a lot about pediatric development of drugs and the misuse of drugs on children. Although I did not read everything word for word, I read the majority of the book. It really opened my eyes to the faults that pediatric drug developers are encounters and the problems these drugs are causing for children. This was an inspirational book, one I truly recommend to anyone looking to pursue a job in a medical field.

BTW, I am not a kid, just wanted to write my review as anonymous and didn't know how to set it as that. So I just wrote it as a kid's review. Thank you.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
 
 
 
Only search this product's reviews



Inside This Book (learn more)
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
suitability petition, clinical research involving children, cognitive applications, cardiology group, child health care, pediatric drug therapy, research involving human subjects, innovative drugs, pediatric legislation, pediatric drug development, juvenile toxicity studies, pediatric regulation, pediatric exclusivity program, juvenile animal studies, juvenile toxicity study, pediatric preclinical testing program, pediatric dosage forms, pediatric participants, true clinical endpoint, pediatric clinical trials, pediatric market, reexamination period, lipase dose, pediatric drug trials, approval lag
Key Phrases - Capitalized Phrases (CAPs): (learn more)
United States, John Wiley, Anker Copyright, New York, Accessed October, Clin Pharmacol Ther, Pediatr Gastroenterol Nutr, Accessed November, Accessed September, International Conference, New Jersey, National Institutes of Health, American Academy of Pediatrics, Arch Dis Child, Oxford University Press, Pediatric Research Equity Act, Pharmacol Exp Ther, Med Ethics, Pediatr Res, Drug Metab Dispos, Clin Nutr, Written Request, Declaration of Helsinki, Clin Oncol, Sampling Time Sampling
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:

Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject